Category: Corporate NewsBy Rameda AdminMay 28, 2024 Author: Rameda Admin Post navigationPreviousPrevious post:BOD-Shareholding-Structure-2024NextNext post:Rameda Announces Price Increase Approvals for All Its Top ProductsRelated PostsRameda Completes Largest Acquisition to DateSeptember 30, 2024Rameda Announces the Establishment of Glow: A Strategic Expansion into the Thriving Freely Priced Cosmeceutical MarketSeptember 9, 2024Earning Release One Pager 2Q24August 13, 2024Rameda Announces Price Increase Approvals for All Its Top ProductsAugust 7, 2024Rameda 4Q23 Earnings ReleaseMarch 20, 2024Rameda Maintains its Impressive Momentum with the Launch of a New Type 2 Diabetes Product, Bolstering its Chronic PortfolioNovember 28, 2023
Rameda Announces the Establishment of Glow: A Strategic Expansion into the Thriving Freely Priced Cosmeceutical MarketSeptember 9, 2024
Rameda Maintains its Impressive Momentum with the Launch of a New Type 2 Diabetes Product, Bolstering its Chronic PortfolioNovember 28, 2023
